New concepts in herpes simplex virus vaccine development: notes from the battlefield
Lipopeptide antigens applied to intravaginal mucosal epithelium are taken up by mucosal resident antigen-presenting cells (APCs), especially DCs/pDCs, which are activated and migrate out of the mucosal inductive sites into the mucosal effector sites of draining lymph nodes where antigen presentation to T cells occurs, resulting in a strong local mucosal immune response. The mucosal immunization with a multivalent lipopeptide vaccine targeting TLR-2 induces an immune mechanism that bridges innate immunity to the ‘asymptomatic’ epitope-specific adaptive T-cell response. DCs are activated through recognition of the lipopeptide by TLR-2 receptors molecules. This triggered activation of the MyD88-dependent pathway and leads to the production of inflammatory cytokines (IL-12, IL-6 and TNF-α), and to phenotypic maturation of APCs (i.e., upregulation of costimulatory and MHC molecules on DCs surface). The multiepitope lipopeptide vaccine is captured, processed and presented by MHC molecules on the matured DCs to T lymphocytes (signal 1: MHC/TCR interaction). This is not sufficient to activate naive T lymphocytes, which need an additional signal from costimulatory molecules (signal 2: B7/CD28), of which expression on DCs is induced by TLR-2 stimulation. Activated T lymphocytes become further differentiated to effector T lymphocytes by stimulation with cytokines such as IL-12.DC: Dendritic cell; HSV: Herpes simplex virus; HTL: Helper T lymphocyte; MyD88: Myeloid differentiation primary response gene 88; pDC: Plasmacytoid dendritic cell; TCR: T-cell receptor; TLR: Toll-like receptor.
Publication
New concepts in herpes simplex virus vaccine development: notes from the battlefield. () Gargi Dasgupta, et al. Expert Rev Vaccines. ;8(8):1023-1035. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Drosophila melanogaster | Invertebrates | (DC | DC | ncbigene_symbol | dc | 44088 |
| Drosophila melanogaster | Invertebrates | and | AND | ncbigene_synonym | CkIIbeta | 32132 |
| Drosophila melanogaster | Invertebrates | and | AND | ncbigene_synonym | Andorra | 32798 |
| Drosophila melanogaster | Invertebrates | and | AND | ncbigene_synonym | Anp | 43595 |
| Drosophila melanogaster | Invertebrates | and | AND | ncbigene_synonym | Acam | 44913 |
| Drosophila melanogaster | Invertebrates | TNF-a) | TNFA | ncbigene_synonym | egr | 36054 |
| Drosophila melanogaster | Invertebrates | TLR2 | TLR2 | ncbigene_symbol | tlr-2 | 44349 |
| Drosophila melanogaster | Invertebrates | MyD88 | MYD88 | ncbigene_symbol | Myd88 | 35956 |
| Drosophila melanogaster | Invertebrates | МНСТCR | CR | ncbigene_symbol | CR | 5657006 |
| Drosophila melanogaster | Invertebrates | МНСТCR | CCR | ncbigene_synonym | Cpr | 33883 |
| Drosophila melanogaster | Invertebrates | Rev. | REV | ncbigene_symbol | Rev | 45924 |
| Homo sapiens | Primates | pDC) | PDC | ncbigene_symbol | PDC | 5132 |
| Homo sapiens | Primates | pDC) | PDC | ncbigene_synonym | PNKD | 25953 |
| Homo sapiens | Primates | CD4 | CD4 | ncbigene_symbol | CD4 | 920 |
| Homo sapiens | Primates | CD8 | CD8 | ncbigene_synonym | CD8A | 925 |
| Homo sapiens | Primates | CD8 | CD8 | famplex_relations | CD8B | 926 |
| Homo sapiens | Primates | IL-6 | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Homo sapiens | Primates | TNF-a) | TNFA | ncbigene_synonym | TNF | 7124 |
| Homo sapiens | Primates | (IL-12, | IL12 | famplex_relations | IL12A | 3592 |
| Homo sapiens | Primates | (IL-12, | IL12 | famplex_relations | IL12B | 3593 |
| Homo sapiens | Primates | TLR2 | TLR2 | ncbigene_symbol | TLR2 | 7097 |
| Homo sapiens | Primates | MyD88 | MYD88 | ncbigene_symbol | MYD88 | 4615 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|